The free-to-use telemedicine system developed by 77 Elektronika Kft. in Hungary is revolutionizing online remote medical services. The project, funded by the National Research, Development and Innovation Fund, aimed to personalise the treatment of patients with or at the early stages of diabetes. That’s why the Dcont® eNAPLÓ platform was created, where people with a Dcont® blood glucose meter can upload their measured data quickly and easily. These are supported by a number of graphs and statistics to help the patient’s orientation and the work of the medical specialist examining the data.

77 Elektronika Kft. is a 100% Hungarian family-owned company, which has been manufacturing its own developed medical electronic devices since 1989, mainly blood glucose monitoring systems and urine testing devices for both personal and laboratory use. In the decades since it was founded, the small family business has grown into a company employing hundreds of people and exporting its products to 100 countries around the world. The company is credited with the popularisation of blood glucose monitoring in Hungary: as early as 1986 it launched its proprietary Dcont® device, which offered Hungarians an affordable alternative to the horrendously priced devices of the period preceding the change of political regime. Since then, the company has remained at the forefront of innovation, investing 6-8% of its annual turnover back into R&D and receiving numerous professional recognitions and awards. Among others, it has twice won the Hungarian Innovation Grand Prize and in 2023 it was awarded the Design Management Prize.

Their latest development, supported by the National Research, Development and Innovation Office, is Dcont® eNAPLÓ, an online platform accessible free of charge to people with diabetes using a Dcont® blood glucose meter. The measured data can be uploaded via an USB cable or, in the case of newer devices, Bluetooth to the eNAPLÓ system, which is available on dcont.hu or as a smartphone app. To make the work of medical specialists easier, since autumn 2022, blood glucose data uploaded to the system will be automatically synchronised with the Electronic Health Service Space (EESZT), and can be accessed immediately by all healthcare professionals with the right authorisation.

77 Elektronika Kft. in cooperation with the South Korean company iSens (the two companies have a 20-year working relationship) has developed a continuous glucose monitoring system (CGM) that measures the patient’s blood glucose every five minutes, providing the doctor with a good opportunity to obtain long-term information about his patient.

Thanks to an innovation by 77 Electronics Kft., patients with diabetes can receive personalised treatment, improving their quality of life and simplifying their medical care. The telemedicine service is therefore a win-win situation: patients feel safer, doctors can treat their patients faster and more efficiently thanks to well-structured data based on up-to-date and real information, and public healthcare systems save time and money.

In the meantime, 77 Elektronika has grown into a group of companies: it has acquired Analyticon in Germany and Metal Ware Kft. in Hungary, established 77 ING Kft. and set up a plant in China, where it manufactures urinalysis laboratory equipment for the Chinese market.